Alembic Pharmaceuticals Dirección
Dirección controles de criterios 3/4
El CEO de Alembic Pharmaceuticals' es Chirayu Amin , nombrado en Apr 2016, tiene una permanencia de 13.83 años. compensación anual total es ₹88.00M, compuesta por 100% salario y 0% primas, incluidas acciones y opciones de la empresa. posee directamente un 2.13% de las acciones de la empresa, por valor de ₹3.99B. La antigüedad media del equipo directivo y de la junta directiva es de 8.5 años y 10 años, respectivamente.
Información clave
Chirayu Amin
Chief Executive Officer (CEO)
₹88.0m
Compensación total
| Porcentaje del salario del CEO | 100.0% |
| Permanencia del CEO | 8.1yrs |
| Participación del CEO | 2.1% |
| Permanencia media de la dirección | 8.6yrs |
| Promedio de permanencia en la Junta Directiva | 10.1yrs |
Actualizaciones recientes de la dirección
Recent updates
Results: Alembic Pharmaceuticals Limited Exceeded Expectations And The Consensus Has Updated Its Estimates
Feb 08
Subdued Growth No Barrier To Alembic Pharmaceuticals Limited (NSE:APLLTD) With Shares Advancing 25%
Jan 21Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?
Jan 05Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly
Sep 27Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly
Jun 09A Look At The Fair Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)
Apr 13Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?
Feb 22Alembic Pharmaceuticals Limited (NSE:APLLTD) Shares Could Be 21% Below Their Intrinsic Value Estimate
Jan 04We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Alembic Pharmaceuticals Limited's (NSE:APLLTD) CEO For Now
Nov 05Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Has A Meaningful Debt Burden
Aug 10Estimating The Intrinsic Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)
Jul 20We Think Alembic Pharmaceuticals (NSE:APLLTD) Is Taking Some Risk With Its Debt
May 05Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly
Jan 17Are Alembic Pharmaceuticals Limited (NSE:APLLTD) Investors Paying Above The Intrinsic Value?
Dec 17These 4 Measures Indicate That Alembic Pharmaceuticals (NSE:APLLTD) Is Using Debt Reasonably Well
Sep 23Is There An Opportunity With Alembic Pharmaceuticals Limited's (NSE:APLLTD) 27% Undervaluation?
Sep 02Here's Why I Think Alembic Pharmaceuticals (NSE:APLLTD) Might Deserve Your Attention Today
Jun 16Alembic Pharmaceuticals (NSE:APLLTD) Has A Pretty Healthy Balance Sheet
May 25Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹6b |
| Sep 30 2023 | n/a | n/a | ₹5b |
| Jun 30 2023 | n/a | n/a | ₹5b |
| Mar 31 2023 | ₹88m | ₹88m | ₹3b |
| Dec 31 2022 | n/a | n/a | ₹2b |
| Sep 30 2022 | n/a | n/a | ₹3b |
| Jun 30 2022 | n/a | n/a | ₹3b |
| Mar 31 2022 | ₹280m | ₹80m | ₹5b |
| Dec 31 2021 | n/a | n/a | ₹8b |
| Sep 30 2021 | n/a | n/a | ₹9b |
| Jun 30 2021 | n/a | n/a | ₹10b |
| Mar 31 2021 | ₹315m | ₹65m | ₹11b |
| Dec 31 2020 | n/a | n/a | ₹12b |
| Sep 30 2020 | n/a | n/a | ₹11b |
| Jun 30 2020 | n/a | n/a | ₹10b |
| Mar 31 2020 | ₹265m | ₹65m | ₹8b |
| Dec 31 2019 | n/a | n/a | ₹7b |
| Sep 30 2019 | n/a | n/a | ₹7b |
| Jun 30 2019 | n/a | n/a | ₹6b |
| Mar 31 2019 | ₹255m | ₹55m | ₹6b |
| Dec 31 2018 | n/a | n/a | ₹6b |
| Sep 30 2018 | n/a | n/a | ₹5b |
| Jun 30 2018 | n/a | n/a | ₹4b |
| Mar 31 2018 | ₹220m | ₹55m | ₹4b |
Compensación vs. Mercado: La compensación total de Chirayu($USD1.06M) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD437.55K).
Compensación vs. Ingresos: La compensación de Chirayu ha sido consistente con los resultados de la empresa en el último año.
CEO
Chirayu Amin (77 yo)
8.1yrs
Permanencia
₹88,000,000
Compensación
Mr. Chirayu Ramanbhai Amin, M.B.A. (U.S.A.), has been Chief Executive Officer of Alembic Pharmaceuticals Limited since April 27, 2016. Mr. Amin served as Managing Director of Alembic Pharmaceuticals Limite...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman & CEO | 8.1yrs | ₹88.00m | 2.13% ₹ 4.2b | |
| MD & Executive Director | 9.1yrs | ₹122.20m | 0.59% ₹ 1.2b | |
| MD & Executive Director | 9.1yrs | ₹122.20m | 0.51% ₹ 1.0b | |
| Director of Finance | no data | ₹56.90m | sin datos | |
| President of Operations | no data | sin datos | sin datos | |
| Chief Scientific Officer | no data | ₹8.41m | sin datos | |
| Company Secretary & Compliance Officer | 1.1yrs | sin datos | sin datos | |
| Chief Business Development Officer | no data | ₹8.30m | 0.51% ₹ 1.0b | |
| Senior Vice President of Human Resources | no data | sin datos | sin datos | |
| Senior Vice President | no data | ₹8.12m | sin datos | |
| Senior Vice President of Finance | no data | ₹9.20m | sin datos | |
| Senior Vice President of Supply Chain | no data | sin datos | sin datos |
8.6yrs
Permanencia media
62.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de APLLTD es experimentado (8.5 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman & CEO | 13.9yrs | ₹88.00m | 2.13% ₹ 4.2b | |
| MD & Executive Director | 13.2yrs | ₹122.20m | 0.59% ₹ 1.2b | |
| MD & Executive Director | 11yrs | ₹122.20m | 0.51% ₹ 1.0b | |
| Director of Finance | 13.9yrs | ₹56.90m | sin datos | |
| Independent Non-Executive Director | 9.3yrs | ₹1.83m | sin datos | |
| Independent Director | less than a year | sin datos | sin datos | |
| Independent Director | 2.3yrs | ₹1.82m | sin datos | |
| Additional Independent Director | less than a year | sin datos | sin datos |
10.1yrs
Permanencia media
56.5yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de APLLTD son experimentados ( 10 años antigüedad media).